US Drug Recall Register
Class III · Low risk Terminated Initiated Jan 29, 2021 (6 years ago)

Auryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufactured for…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Dissolution Specifications

What was recalled

Auryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC., 245 First Street, Suite 1400, Cambridge, MA 02142, USA, NDC 59922-0631-01.

Recalling firm
Akebia Therapeutics dba Keryx Biopharmaceutials, Inc
NDC code
59922-0631-01
Origin
MA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0260-2021

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Ferric recalls

See all